机构:[1]Department of Vascular Surgery, Xuanwu Hospital, Beijing, China血管外科首都医科大学宣武医院[2]Capital Medical University, Institute of Vascular Surgery, Capital Medical University, Beijing, China[3]Section of Vascular Surgery, Yale University, New Haven, Connecticut[4]Vascular Biology and Therapeutics, Yale University School of Medicine, New Haven, Connecticut.
Background: Patients presenting a carotid stenosis and contralateral carotid occlusion (CCO) have been historically considered at high risk of carotid surgical treatment, and there are few data regarding short-term recovery after stenting therapy in patients with CCO. The aim of this study is to evaluate the short-term recovery and safety of stenting for patients with CCO and different subgroup population. Methods: We retrospectively reviewed the records of consecutive patients with CCO who were treated with stenting endovascular methods between 2008 and 2014. The postoperative outcomes were analyzed according to age, ischemic symptom, cerebral infarction history, and collateral situation subgroups, respectively. Results: Fifty-eight consecutive patients with CCO were treated and 49 (84.5%) completed a 3-year follow-up. There were significant higher stroke, myocardial infarction, or death events in the aged (>= 75 years old) group and poor collateral group (P =.007 and.0024, respectively). There was no difference in the 3-year primary endpoint incidence between the cerebral ischemia symptom subgroups and cerebral infarction history subgroups. Event-free survival, aged group, and poor collateral group were lower (P =.007 and P =.0024, respectively). Conclusions: Carotid artery stenting (CAS) for patients with common carotid artery is a safe and effective therapy. Factors such as age 75 years or older and poor collateral are associated with a higher 3-year rate of postprocedural stroke, myocardial infarction and death, and lower event-free survival in patients with CCO treated by CAS. Meanwhile, our data do not show a significant impact of cerebral ischemic symptom and cerebral infarction history on clinical outcome of patients with CCO undergoing CAS. (c) 2018 National Stroke Association. Published by Elsevier Inc. All rights reserved.
基金:
the Beijing Municipal Administration of Hospitals Clinical Technology Innovation Program [Grant No. XMLX201610]
Beijing Municipal Administration of Hospitals Climbing Talent Training Program [Grant No. DFL20150801],
Beijing Outstanding Talents Project [Grant No. 2016000020124G108],
Beijing Municipal Science and Technology Commission Clinical Features Applied Research Projects [Grant No. Z141107002514063]
Beijing Municipal Administration of Hospitals Incubating Program [Grant No. PX2018035].
第一作者机构:[1]Department of Vascular Surgery, Xuanwu Hospital, Beijing, China[2]Capital Medical University, Institute of Vascular Surgery, Capital Medical University, Beijing, China
通讯作者:
通讯机构:[*1]Department of Vascular Surgery, Xuanwu Hospital, China.
推荐引用方式(GB/T 7714):
Jianming Guo,Lianrui Guo,Zhu Tong,et al.Three-Year Clinical Results of Carotid Artery Stenting in Treating Patients with Contralateral Carotid Artery Occlusion[J].JOURNAL OF STROKE & CEREBROVASCULAR DISEASES.2018,27(5):1296-1301.doi:10.1016/j.jstrokecerebrovasdis.2017.12.016.
APA:
Jianming Guo,Lianrui Guo,Zhu Tong,Zhonggao Wang,Alan Dardik&Yongquan Gu.(2018).Three-Year Clinical Results of Carotid Artery Stenting in Treating Patients with Contralateral Carotid Artery Occlusion.JOURNAL OF STROKE & CEREBROVASCULAR DISEASES,27,(5)
MLA:
Jianming Guo,et al."Three-Year Clinical Results of Carotid Artery Stenting in Treating Patients with Contralateral Carotid Artery Occlusion".JOURNAL OF STROKE & CEREBROVASCULAR DISEASES 27..5(2018):1296-1301